Technology
Kemin enhances global enzyme production with CJ Youtell Biotech acquisition

Siân Yates
26 September 2025
26 September 2025
Kemin enhances global enzyme production with CJ Youtell Biotech acquisition

Kemin Industries, a global ingredient manufacturer, has acquired CJ Youtell Biotech, the enzymes and fermentation subsidiary of CJ Bio.
This acquisition enhances Kemin's enzyme production capabilities and solidifies its position as a frontrunner in enzyme innovation across multiple sectors, including animal feed, food processing, aquaculture, textiles and biofuels.
The acquisition grants Kemin full ownership of CJ Youtell's fermentation plants and its extensive enzyme product portfolio. Notably, CJ Youtell operates state-of-the-art fermentation facilities located in Shandong and Hunan, China, which will now be integrated into Kemin's existing operations.
This move is expected to streamline Kemin's supply chain and expand its market reach, enabling the company to deliver high-performance, sustainable enzyme technologies to a global customer base.
Chris Nelson, president and CEO of Kemin Industries, said: “We are pleased to welcome CJ Youtell into the Kemin family. This acquisition is a bold step forward in our ongoing strategy to provide cutting-edge fermentation solutions directly to our customers.”
Nelson also pointed out that the addition of CJ Youtell enhances Kemin’s ability to supply high-quality and innovative enzyme ingredients across various industries.
The acquisition is poised to bolster Kemin's research and development capabilities, with the newly acquired facilities supporting advanced laboratories and technical teams specialising in bioengineering and enzyme formulation.
This enhancement will enable Kemin to optimise production costs, reduce supply chain risks and offer competitively priced enzyme solutions tailored to the specific needs of its diverse clientele.
Michelle Lim, president of Kemin Enzymes, added: “For over 40 years, Kemin has been formulating and delivering enzyme solutions across multiple markets. With CJ Youtell's fermentation expertise now part of our portfolio, we offer customers a fully integrated solution – from proprietary strain development and manufacturing to final formulation and application support.”
By combining in-house fermentation with advanced formulation techniques and comprehensive technical support, Kemin is well-positioned to meet the evolving demands of its customers, ensuring they remain competitive in rapidly changing markets.
Kemin Industries, established in 1961, operates in over 90 countries and provides more than 500 specialty ingredients for human and animal health, nutrition and various industrial applications.
Related news
Pow.Bio expands continuous fermentation process to 3,000 litre with Bühler and ATV
Pow.Bio has scaled its continuous biomanufacturing platform to 3,000 litres at ATV Technologies’ facility in Compiègne, France, marking a major milestone in the industrial validation of its technology.
Symrise invests in US biotech firm Cellibre to advance fermentation-based ingredient innovation
Symrise has announced a strategic equity investment in Cellibre, a US-based biotechnology company focused on sustainable biomanufacturing.
Queensland University of Technology announces $11.8m investment in fermentation facility
Australia’s Queensland University of Technology (QUT) has invested AUD 18 million (approx. $11.8 million) into its Mackay-based QUT Pioneer BioPilot, an upgraded, pilot-scale fermentation and biomanufacturing facility.
Opinion: Fermentation at scale – A path to affordable, nutritious and climate resilient protein
When it comes to protein, price has always been a key driver for consumers, followed by nutrition. Felipe Lino, co-founder and chief technology officer at Berlin-based fermentation company Nosh.bio, tells us more.
Technology
Kemin enhances global enzyme production with CJ Youtell Biotech acquisition

Siân Yates
26 September 2025



